KuriBio

KuriBio is transforming cancer treatment through breakthrough targeted nanotechnology. Current chemotherapies often come too late, extend life by only months, and cause devastating side effects. Our rationally-designed nanoparticles revolutionize this approach by precisely targeting cancer cells while sparing healthy tissue. This platform enables both earlier detection and more effective treatment, delivering therapeutic agents directly to the tumor microenvironment. By dramatically reducing side effects while improving efficacy, we’re creating a new paradigm in cancer care that could significantly extend and improve patients’ lives.